Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Journal of Clinical Oncology

Volumn 18, Issue 10, 2000, Pages 2081-2086

  Verweij, Jaap ^a   Lee, Siow Ming ^a   Ruka, Wlodzimir ^a   Buesa, Jose ^a   Coleman, Robert ^a   Van Hoessel, Rene ^a   Seynaeve, Caroline ^a   di Paola, Eugenio Donato ^a   van Glabbeke, Martine ^a   Tonelli, D ^a   Judson, Ian R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; DOXORUBICIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; FEMALE; GRANULOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROTOXICITY; OSTEOSARCOMA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; STOMATITIS; TREATMENT INDICATION; VOMITING;

EID: 18144448739     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.10.2081     Document Type: Article

References (21)

1. Simon MA, Spainer SS, Enneking WF: Management of adult soft tissue sarcomas of the extremities. Ann Surg 1:363-402, 1979
2. Brennan MF, Shiu MH, Collin C, et al: Extremity soft tissue sarcomas. Cancer Treat Symp 3:71-81, 1985
3. Windyer SB, Dische S, Mansfield CM: The place of radiotherapy in the management of fibrosarcoma of the soft tissues. Clin Radiol 17:32-40, 1966
4. Lindberg RD, Martin RG, Romsdahl MM, et al: Conservative surgery and postoperative radiotherapy in 300 adults with soft tissue sarcomas. Cancer 47:2391-2397, 1981
5. Tepper JE, Suit HD: Radiation therapy of soft tissue sarcomas. Cancer 55:2273-2277, 1985
6. Verweij J, Mouridsen HT, Nielsen OS, et al: The present state of the art in chemotherapy for soft tissue sarcomas in adults: The EORTC point of view. Crit Rev Oncol Hematol 20:193-201, 1995
7. Benjamin RS, Legha SS, Patel SR, et al: Single agent ifosfamide studies in sarcomas of soft tissue and bone: The MD Anderson experience. Cancer Chemother Pharmacol 31:174-179, 1993 (suppl 2)
8. Schoenfeld DA, Rosenbaum C, Horton J, et al: A comparison of Adriamycin versus vincristine and Adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer 50:2757-2762, 1982
9. Borden EC, Amato DA, Rosenbaum C, et al: Randomized comparison of three Adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 5:840-850, 1987
10. Santoro A, Tursz T, Mouridsen H, et al: Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the EORTC Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13:1537-1545, 1995
11. van Hoesel QGCM, Verweij J, Catimel G, et al: Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult: EORTC Soft Tissue and Bone Sarcoma Group. Ann Oncol 5:539-542, 1994
12. Edmonson JH, Ebbert LP, Nascimento AG, et al: Phase II study of docetaxel in advanced soft tissue sarcomas. Am J Clin Oncol 19:574-576, 1996
13. Trojani M, Contesso G, Coindre JM, et al: Soft tissue sarcomas of adults: Study of pathological and prognostic variables and definition of a histological grading system. Int J Cancer 33:37-42, 1984
14. World Health Organization: Handbook for Reporting Results of Cancer Treatment. WHO publication no. 48. Geneva, Switzerland, World Health Organization, 1979
15. Freedman LS: Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1:121-129, 1982
16. Simon R: Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1-10, 1989
17. Bramwell V, Blackstein M, Berlanger K, et al: A phase II study of docetaxel in chemotherapy-naive patients with recurrent or metastatic adult soft tissue sarcoma. Sarcoma 2:29-33, 1998
18. Balcerzak SP, Benedetti J, Weiss GR, et al: A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas: A Southwest Oncology Group study. Cancer 76:2248-2252, 1995
19. Gian VG, Johnson TJ, Marsh RW, et al: A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue or bone sarcomas. J Exp Ther Oncol 1:186-190, 1996
20. Casper ES, Waltzman RJ, Schwartz GK, et al: Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest 16:442-446, 1998
21. van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al: Prognostic factors for the outcome of chemotherapy in advanced sarcoma: An analysis on 2185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 17:150-157, 1999